A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
- PMID:11728344
- DOI: 10.1016/s1074-7613(01)00232-1
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
Abstract
TWEAK is a member of the TNF ligand family that induces angiogenesis in vivo. We report cloning of a receptor for TWEAK (TweakR) from a human umbilical vein endothelial cell (HUVEC) library. The mature form of TweakR has only one hundred and two amino acids and six cysteine residues in its extracellular region. Five different assays demonstrate TWEAK-TweakR binding, and the interaction affinity constant (Kd) is within a physiologically relevant range of 2.3 +/- 0.1 nM. The TweakR cytoplasmic domain binds TRAFs 1, 2, and 3. Cross-linking of TweakR induces HUVEC growth, and mRNA levels are upregulated in vitro by a variety of agents and in vivo following arterial injury. Soluble TweakR inhibits endothelial cell migration in vitro and corneal angiogenesis in vivo.
Similar articles
- TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.Wiley SR, Winkles JA.Wiley SR, et al.Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. doi: 10.1016/s1359-6101(03)00019-4.Cytokine Growth Factor Rev. 2003.PMID:12787562Review.
- Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, Okumura K.Harada N, et al.Biochem Biophys Res Commun. 2002 Dec 6;299(3):488-93. doi: 10.1016/s0006-291x(02)02670-0.Biochem Biophys Res Commun. 2002.PMID:12445828
- A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.Bover LC, Cardó-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R.Bover LC, et al.J Immunol. 2007 Jun 15;178(12):8183-94. doi: 10.4049/jimmunol.178.12.8183.J Immunol. 2007.PMID:17548657
- TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T.Polek TC, et al.J Biol Chem. 2003 Aug 22;278(34):32317-23. doi: 10.1074/jbc.M302518200. Epub 2003 Jun 6.J Biol Chem. 2003.PMID:12794080
- The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.Campbell S, Michaelson J, Burkly L, Putterman C.Campbell S, et al.Front Biosci. 2004 Sep 1;9:2273-84. doi: 10.2741/1395.Front Biosci. 2004.PMID:15353286Review.
Cited by
- Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model.Lu Q, Yao Y, Yao Y, Liu S, Huang Y, Lu S, Bai Y, Zhou B, Xu Y, Li L, Wang N, Wang L, Zhang J, Cheng X, Qin G, Ma W, Xu C, Tu X, Wang Q.Lu Q, et al.PLoS One. 2012;7(10):e46998. doi: 10.1371/journal.pone.0046998. Epub 2012 Oct 23.PLoS One. 2012.PMID:23110058Free PMC article.
- Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer.Ju HY, Youn SY, Kang J, Whang MY, Choi YJ, Han MR.Ju HY, et al.Biomark Res. 2024 Aug 12;12(1):80. doi: 10.1186/s40364-024-00632-7.Biomark Res. 2024.PMID:39135097Free PMC article.
- Targeted ablation of Fn14 receptor improves exercise capacity and inhibits neurogenic muscle atrophy.Tomaz da Silva M, Joshi AS, Koike TE, Roy A, Mathukumalli K, Sopariwala DH, Narkar VA, Kumar A.Tomaz da Silva M, et al.FASEB J. 2022 Dec;36(12):e22666. doi: 10.1096/fj.202201583R.FASEB J. 2022.PMID:36412933Free PMC article.
- Temporal Splicing Switches in Elements of the TNF-Pathway Identified by Computational Analysis of Transcriptome Data for Human Cell Lines.Genov N, Basti A, Abreu M, Relógio A.Genov N, et al.Int J Mol Sci. 2019 Mar 8;20(5):1182. doi: 10.3390/ijms20051182.Int J Mol Sci. 2019.PMID:30857150Free PMC article.
- Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.Chen T, Guo ZP, Li MM, Li JY, Jiao XY, Zhang YH, Liu HJ.Chen T, et al.Clin Exp Immunol. 2011 Oct;166(1):64-71. doi: 10.1111/j.1365-2249.2011.04442.x. Epub 2011 Jul 15.Clin Exp Immunol. 2011.PMID:21762126Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases